Prediction of clinical transporter‐mediated drug–drug interactions via comeasurement of pitavastatin and eltrombopag in human hepatocyte Models

[thumbnail of WRAP-Prediction-clinical-transporter-mediated-drug–drug-2020.pdf]
Preview
PDF
WRAP-Prediction-clinical-transporter-mediated-drug–drug-2020.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution 4.0.

Download (470kB) | Preview

Request Changes to record.

Abstract

A structurally identifiable micro‐rate constant mechanistic model was used to describe the interaction between pitavastatin and eltrombopag, with improved goodness‐of‐fit values through comeasurement of pitavastatin and eltrombopag. Transporter association and dissociation rate constants and passive rates out of the cell were similar between pitavastatin and eltrombopag. Translocation into the cell through transporter‐mediated uptake was six times greater for pitavastatin, leading to pronounced inhibition of pitavastatin uptake by eltrombopag. The passive rate into the cell was 91 times smaller for pitavastatin compared with eltrombopag. A semimechanistic physiologically‐based pharmacokinetic (PBPK) model was developed to evaluate the potential for clinical drug–drug interactions (DDIs). The PBPK model predicted a twofold increase in the pitavastatin peak blood concentration and area under the concentration‐time curve in the presence of eltrombopag in simulated healthy volunteers. The use of structural identifiability supporting experimental design combined with robust micro‐rate constant parameter estimates and a semimechanistic PBPK model gave more informed predictions of transporter‐mediated DDIs.

Item Type: Journal Article
Subjects: R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Science, Engineering and Medicine > Engineering > Engineering
Library of Congress Subject Headings (LCSH): Drug interactions , Pharmacokinetics , Drugs -- Metabolism -- Evaluation
Journal or Publication Title: CPT: pharmacometrics & systems pharmacology
Publisher: Wiley-Blackwell Publishing Ltd.
ISSN: 2163-8306
Official Date: April 2020
Dates:
Date
Event
April 2020
Published
6 March 2020
Available
27 January 2020
Accepted
Volume: 9
Number: 4
Page Range: pp. 211-221
DOI: 10.1002/psp4.12505
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access (Creative Commons open licence)
Copyright Holders: © 2020 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics.
Date of first compliant deposit: 8 March 2021
Date of first compliant Open Access: 9 March 2021
RIOXX Funder/Project Grant:
Project/Grant ID
RIOXX Funder Name
Funder ID
1548253
[BBSRC] Biotechnology and Biological Sciences Research Council
URI: https://wrap.warwick.ac.uk/149520/

Export / Share Citation


Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item